Tower Research Capital LLC (Trc) Poseida Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

$4.87 Billion
Q4 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Poseida Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,340 shares of PSTX stock, worth $31,730. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,340

Previous 3,192 4.64%

Holding current value

$31,730

Previous $9,000 255.56%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$2.37 - $9.6 $350 - $1,420	148 Added 4.64%	3,340 $32,000
Q3 2024 Nov 14, 2024	SELL	$2.7 - $4.04 $21,335 - $31,924	-7,902 Reduced 71.23%	3,192 $9,000
Q2 2024 Aug 13, 2024	BUY	$2.0 - $3.46 $8,806 - $15,234	4,403 Added 65.8%	11,094 $32,000
Q1 2024 May 15, 2024	SELL	$2.76 - $4.13 $11,006 - $16,470	-3,988 Reduced 37.34%	6,691 $21,000
Q4 2023 Feb 13, 2024	BUY	$1.83 - $3.51 $10,258 - $19,677	5,606 Added 110.51%	10,679 $35,000
Q3 2023 Nov 14, 2023	SELL	$1.62 - $2.79 $3,061 - $5,273	-1,890 Reduced 27.14%	5,073 $12,000
Q2 2023 Aug 14, 2023	SELL	$1.66 - $3.4 $16,314 - $33,415	-9,828 Reduced 58.53%	6,963 $12,000
Q1 2023 May 09, 2023	BUY	$3.08 - $8.73 $35,235 - $99,871	11,440 Added 213.79%	16,791 $51,000
Q4 2022 Feb 10, 2023	SELL	$3.33 - $6.38 $7,009 - $13,429	-2,105 Reduced 28.23%	5,351 $28,000
Q3 2022 Nov 10, 2022	SELL	$2.43 - $4.51 $1,244 - $2,309	-512 Reduced 6.43%	7,456 $26,000
Q2 2022 Aug 15, 2022	BUY	$1.87 - $5.0 $9,271 - $24,790	4,958 Added 164.72%	7,968 $20,000
Q1 2022 May 12, 2022	BUY	$3.22 - $7.04 $4,591 - $10,039	1,426 Added 90.03%	3,010 $13,000
Q4 2021 Feb 14, 2022	SELL	$6.23 - $7.6 $1,682 - $2,052	-270 Reduced 14.56%	1,584 $11,000
Q3 2021 Nov 15, 2021	SELL	$7.09 - $10.71 $4,438 - $6,704	-626 Reduced 25.24%	1,854 $13,000
Q2 2021 Aug 16, 2021	SELL	$7.96 - $10.07 $4,935 - $6,243	-620 Reduced 20.0%	2,480 $25,000
Q1 2021 May 17, 2021	SELL	$8.51 - $11.91 $12,952 - $18,127	-1,522 Reduced 32.93%	3,100 $30,000
Q4 2020 Feb 16, 2021	BUY	$8.29 - $11.7 $18,039 - $25,459	2,176 Added 88.96%	4,622 $51,000
Q3 2020 Nov 16, 2020	BUY	$8.09 - $16.25 $19,788 - $39,747	2,446 New	2,446 $22,000

Others Institutions Holding PSTX

# of Institutions

119

Shares Held

40.7M

Call Options Held

135K

Put Options Held

439K

View Full List

About Poseida Therapeutics, Inc.

Ticker PSTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,775,600
Market Cap $815M
Description
Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...

More about PSTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Poseida Therapeutics, Inc. Transaction History